MilliporeSigma
All Photos(1)

C6653

Supelco

Carbonic Anhydrase I from human erythrocytes

Isoelectric focusing marker, pI 6.6

Synonym(s):
Carbonate Dehydratase, Carbonic Anhydrase Isozyme I, Carbonate Hydrolyase
CAS Number:
Enzyme Commission number:
EC Number:
MDL number:
NACRES:
NA.25

Quality Level

form

powder

pI 

6.6

storage temp.

−20°C

Looking for similar products? Visit Product Comparison Guide

Related Categories

Application

Carbonic Anhydrase I from human erythrocytes has been used as a pI (isoelectric point) marker in two-dimensional gel electrophoresis.

Biochem/physiol Actions

Carbonic Anhydrase I from human erythrocytes is a protein which is used as a standard pI (isoelectric point) marker for isoelectric focussing experiments.

Storage Class Code

13 - Non Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificate of Analysis

Enter Lot Number to search for Certificate of Analysis (COA).

Certificate of Origin

Enter Lot Number to search for Certificate of Origin (COO).

Product Information Sheet

More Documents

Quotes and Ordering

The focusing positions of polypeptides in immobilized pH gradients can be predicted from their amino acid sequences.
Bjellqvist B, et al.
Electrophoresis, 14, 1023-1031 (1993)
Forskolin and camptothecin induce a 30 kDa protein associated with melatonin production in Y79 human retinoblastoma cells.
Janavs JL, et al.
The Journal of Neuroscience, 15, 298-309 (1995)
Two-dimensional gel isoelectric focusing.
Stastna M and Slais K
Electrophoresis, 26, 3586-3591 (2005)
Yuzhu Bian et al.
Artificial cells, nanomedicine, and biotechnology, 41(1), 60-68 (2013-01-26)
Even though erythrocytes transport both oxygen and carbon dioxide, research on blood substitutes has concentrated on the transport of oxygen and its vasoactivity and oxidative effects. Recent study in a hemorrhagic shock animal model shows that the degree of tissue
Barend Andre Stander et al.
PloS one, 7(12), e52205-e52205 (2013-01-10)
Antimitotic compounds are still one of the most widely used chemotherapeutic anticancer drugs in the clinic today. Given their effectiveness against cancer it is beneficial to continue enhancing these drugs. One way is to improve the bioavailability and efficacy by

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service